Sat Akal Remedies Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 85.69%
(FY 2019)
- Profit 112.37%
(FY 2019)
- Ebitda -759.89%
(FY 2019)
- Net Worth 10.52%
(FY 2019)
- Total Assets -1.33%
(FY 2019)
About Sat Akal Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Amrik Singh, Jorawar Rathore, Jasveer Singh, and One other member serve as directors at the Company.
- CIN/LLPIN
U74900DL2013PTC259542
- Company No.
259542
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Oct 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sat Akal Remedies Private Limited offer?
Sat Akal Remedies Private Limited offers a wide range of products and services, including Dinnerware and Serving Utensils, Copper Utensils, Marble God Statue, Marble Ganesh Statue, Storage Basket, Aluminum Baskets, Cane Craft, Cane Baskets, Kitchen Cleaners, Cleaning Scrubbers.
Who are the key members and board of directors at Sat Akal Remedies?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amrik Singh  | Director | 09-Dec-2015 | Current |
| Jorawar Rathore | Director | 24-Oct-2013 | Current |
| Jasveer Singh | Director | 09-Dec-2015 | Current |
| Gurcharan Singh | Director | 10-Jun-2015 | Current |
Financial Performance of Sat Akal Remedies.
Sat Akal Remedies Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 85.69% increase. The company also saw a substantial improvement in profitability, with a 112.37% increase in profit. The company's net worth Soared by an impressive increase of 10.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sat Akal Remedies?
In 2019, Sat Akal Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jsr Realbuild Private LimitedActive 12 years 8 monthsAmrik Singh, Jorawar Rathore and 1 more are mutual person
Well-Era Medical Supplies LlpActive 4 years 5 monthsAmrik Singh, Jorawar Rathore and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sat Akal Remedies?
Unlock and access historical data on people associated with Sat Akal Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sat Akal Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sat Akal Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
